+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Microwave Ablation Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Microwave Ablation Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
From
Sickle Cell Disease - Competitive landscape, 2023 - Product Thumbnail Image

Sickle Cell Disease - Competitive landscape, 2023

  • Report
  • May 2023
  • 196 Pages
  • Global
From
Digital Marketing Trends in Type 2 Diabetes - Product Thumbnail Image

Digital Marketing Trends in Type 2 Diabetes

  • Report
  • June 2023
  • 34 Pages
  • Global
From
From
From
From
C5a Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

C5a Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cell Dissociation Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cell Dissociation Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
siRNA Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

siRNA Therapeutics Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 195 Pages
  • Global
From
Loading Indicator